Figure 1From: Leishmania tarentolae: an alternative approach to the production of monoclonal antibodies to treat emerging viral infectionsThe structures of native IgG, scFv and bivalent scFv-Fc fusion molecules. Red and green: variable domains; blue: constant domains; brown: disulphide bonds; orange: artificial peptide linker.Back to article page